Mi Kryviy Rih Center of Dnipropetrovsk Regional Council

Charleroi 6000

0 studies enrolling now · 1 studies all time

What they study most

Advanced Malignancies, Metastatic Cancer

Studies at this site

• Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies — Completed